Sanofi Pasteur is allowed to sell ‘Menactra’ in Korea
Sanofi Pasteur (president Regis Launay) announced that ‘Menactra’, a meningococcal (Groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine, receivedmarketing authorization from the Ministry of Food and Drug Safety on the 21st.
Menactra, the top-ranked drug (in sales)among o...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
